Global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021 and projection to 2050: A systematic analysis for the global burden of disease study 2021
PLOS One · 29.12.2025 · 20 (12) · e0338335
DOI: 10.1371/journal.pone.0338335 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 29.12.2025. Verfasst von Changyong Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Cost of Illness, Global Burden of Disease, Global Health. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major Project of Yunnan University Medical Research Fund, Yunnan Provincial Training Project of High-level Talents.
Abstract (Originalsprache)
Background
Pulmonary arterial hypertension (PAH) is a progressive and incurable syndrome characterized by pulmonary vascular remodeling. Although targeted therapies have advanced, prognosis remains poor, underscoring the need for comprehensive epidemiological evaluations to guide public health strategies and resource allocation.
Methods
This study assessed the global, regional, and national burden of PAH from 1990 to 2021 using data from the Global Burden of Disease Study (GBD) 2021. Metrics included prevalence, incidence, mortality, and disability-adjusted life years (DALYs), with stratified assessments by geography, gender, age, and socio-demographic index (SDI).
Results
In 2021, the global PAH burden comprised 191,808 prevalent cases, 43,251 incident cases, 22,021 deaths, and 642,104 DALYs. Age-standardized rates declined consistently over the 32-year period. Population growth was the prominent contributor of the PAH burden, with higher rates in females and older age groups. Prevalence, mortality, and DALYs decreased with higher SDI, whereas incidence showed an inverse trend. The disparity between high and low SDI countries widened, with the slope index of inequality increasing from −5.21 in 1990 to −1.52 in 2021. Predictions revealed that further declines in age-standardized rates of prevalence, mortality, and DALYs from 2022 to 2025, but a rise in incidence.
Conclusions
A decline in the age-standardized rates of PAH was observed, whereas a persisting high absolute disease burden was evident, clustering among women, older populations, and low-SDI regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Department of Emergency, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Department of Cardiology, The Affiliated Hospital of Yunnan University, Kunming, China.
ORCID-Profile: Changyong Wu, Yunzhu Peng
Förderung
- National Natural Science Foundation of China
- Major Project of Yunnan University Medical Research Fund
- Yunnan Provincial Training Project of High-level Talents
- Medical leading Talents Training Program of Yunnan Provincial Health Commission
Zitieren
APA
Wu, C., Wang, Z., Luo, Y., Sun, H., Li, R., Liu, W., Xu, F., Zhang, B., & Peng, Y. (2025). Global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021 and projection to 2050: A systematic analysis for the global burden of disease study 2021. PLOS One, 20(12), e0338335. https://doi.org/10.1371/journal.pone.0338335
Vancouver
Wu C, Wang Z, Luo Y, Sun H, Li R, Liu W, et al. Global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021 and projection to 2050: A systematic analysis for the global burden of disease study 2021. PLOS One. 2025;20(12):e0338335. doi:10.1371/journal.pone.0338335
BibTeX
@article{Wu2025,
author = {Wu, Changyong and Wang, Zhongkai and Luo, Yihua and Sun, Huang and Li, Ruijie and Liu, Weijie and Xu, Fei and Zhang, Bingqing and Peng, Yunzhu},
title = {Global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021 and projection to 2050: A systematic analysis for the global burden of disease study 2021},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {12},
pages = {e0338335},
doi = {10.1371/journal.pone.0338335}
}
EUVIMED